Pyritinol Hydrochloride and Cognitive Functions: Influence on Children in Slow Learner Classes View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

1975-09

AUTHORS

U Wälti, M Kuenzler, J Schild, F Vassella, E Pavlincova, J Bircher, N Herschkowitz

ABSTRACT

Pyritinol-HCl was tested for its impact on the cognitive functions of children with learning disabilities. This study is a contribution to scientific discussion on the complicated methodologic problems in evaluating the clinical efficacy of psychopharmacologic agents. Sixty-seven pupils of slow learner classes between the ages of 11 and 16 years were treated for 6 months with 300 mg pyritinol-HCl/24 hr or placebo under strict double-blind conditions. Drug intake was stimulated and controlled by means of intense psychosocial interaction with the mothers of the subjects. The dependence variables used to test medication effects were 22 parameters of cognitive performance measured in psychologic tests for perceptual and intellectual functions which were administered immediately before and after the medication phase. First the gainscores before and after treatment with pyritinol or placebo within the 22 cognitive parameters were statistically compared. In addition, an analysis of covariance on the corrected results of the second test (treating the results of first testing as covariates) and a two group discriminant analysis for overall differences were performed. None of the 22 parameters showed statistically significant treatment effects with respect to average performance (t (pyritinol - placebo) = 1.96 to 1.31), neither could the two groups be separated by discriminant analysis (Hotelling's T2 = 35.4, df - 22 and 43, P = 0.465). With respect to a variability of gainscores, however, in four parameters there was a significantly higher variance in the pyritinol group (F = 1.85-2.33, P less than 0.05, less than 0.02, respectively). This fact may signify that pyritinol-HCl had different effects on different subjects. By means of prognostic stratification we therefore attempted to define objective criteria for a selection of subjects with probable positive treatment effects. None of the 15 tested criteria, such as body weight, age, perceptual handicaps, or reduced short term memory, IQ range, proved, however, to be critical for a prognosis of pyritinol effects within the present test population. More... »

PAGES

717

Identifiers

URI

http://scigraph.springernature.com/pub.10.1203/00006450-197509000-00006

DOI

http://dx.doi.org/10.1203/00006450-197509000-00006

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1030675497

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/1105370


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1701", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Psychology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/17", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Psychology and Cognitive Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Age Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Attention", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Body Weight", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Clinical Trials as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cognition", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Evaluation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Intelligence Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Learning Disorders", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Memory, Short-Term", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Perception", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Placebos", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyridines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyrithioxin", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Bern", 
          "id": "https://www.grid.ac/institutes/grid.5734.5", 
          "name": [
            "Departments of Pediatrics, Neurology, and Clinical Pharmacology, University of Berne, Berne, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "W\u00e4lti", 
        "givenName": "U", 
        "id": "sg:person.066315337.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.066315337.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Bern", 
          "id": "https://www.grid.ac/institutes/grid.5734.5", 
          "name": [
            "Departments of Pediatrics, Neurology, and Clinical Pharmacology, University of Berne, Berne, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kuenzler", 
        "givenName": "M", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Bern", 
          "id": "https://www.grid.ac/institutes/grid.5734.5", 
          "name": [
            "Departments of Pediatrics, Neurology, and Clinical Pharmacology, University of Berne, Berne, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schild", 
        "givenName": "J", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Bern", 
          "id": "https://www.grid.ac/institutes/grid.5734.5", 
          "name": [
            "Departments of Pediatrics, Neurology, and Clinical Pharmacology, University of Berne, Berne, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vassella", 
        "givenName": "F", 
        "id": "sg:person.07671227605.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07671227605.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Bern", 
          "id": "https://www.grid.ac/institutes/grid.5734.5", 
          "name": [
            "Departments of Pediatrics, Neurology, and Clinical Pharmacology, University of Berne, Berne, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pavlincova", 
        "givenName": "E", 
        "id": "sg:person.0104106472.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0104106472.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Bern", 
          "id": "https://www.grid.ac/institutes/grid.5734.5", 
          "name": [
            "Departments of Pediatrics, Neurology, and Clinical Pharmacology, University of Berne, Berne, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bircher", 
        "givenName": "J", 
        "id": "sg:person.071566117.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.071566117.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Bern", 
          "id": "https://www.grid.ac/institutes/grid.5734.5", 
          "name": [
            "Departments of Pediatrics, Neurology, and Clinical Pharmacology, University of Berne, Berne, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Herschkowitz", 
        "givenName": "N", 
        "id": "sg:person.0732503263.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0732503263.77"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1975-09", 
    "datePublishedReg": "1975-09-01", 
    "description": "Pyritinol-HCl was tested for its impact on the cognitive functions of children with learning disabilities. This study is a contribution to scientific discussion on the complicated methodologic problems in evaluating the clinical efficacy of psychopharmacologic agents. Sixty-seven pupils of slow learner classes between the ages of 11 and 16 years were treated for 6 months with 300 mg pyritinol-HCl/24 hr or placebo under strict double-blind conditions. Drug intake was stimulated and controlled by means of intense psychosocial interaction with the mothers of the subjects. The dependence variables used to test medication effects were 22 parameters of cognitive performance measured in psychologic tests for perceptual and intellectual functions which were administered immediately before and after the medication phase. First the gainscores before and after treatment with pyritinol or placebo within the 22 cognitive parameters were statistically compared. In addition, an analysis of covariance on the corrected results of the second test (treating the results of first testing as covariates) and a two group discriminant analysis for overall differences were performed. None of the 22 parameters showed statistically significant treatment effects with respect to average performance (t (pyritinol - placebo) = 1.96 to 1.31), neither could the two groups be separated by discriminant analysis (Hotelling's T2 = 35.4, df - 22 and 43, P = 0.465). With respect to a variability of gainscores, however, in four parameters there was a significantly higher variance in the pyritinol group (F = 1.85-2.33, P less than 0.05, less than 0.02, respectively). This fact may signify that pyritinol-HCl had different effects on different subjects. By means of prognostic stratification we therefore attempted to define objective criteria for a selection of subjects with probable positive treatment effects. None of the 15 tested criteria, such as body weight, age, perceptual handicaps, or reduced short term memory, IQ range, proved, however, to be critical for a prognosis of pyritinol effects within the present test population.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1203/00006450-197509000-00006", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1007352", 
        "issn": [
          "0031-3998", 
          "1530-0447"
        ], 
        "name": "Pediatric Research", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "9", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "9"
      }
    ], 
    "name": "Pyritinol Hydrochloride and Cognitive Functions: Influence on Children in Slow Learner Classes", 
    "pagination": "717", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "92226115291bac5201d2f0ebc9ea8d5719f2e711357cb56e571702b026f45a32"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "1105370"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0100714"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1203/00006450-197509000-00006"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1030675497"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1203/00006450-197509000-00006", 
      "https://app.dimensions.ai/details/publication/pub.1030675497"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T17:19", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8672_00000425.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/pr1975227"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1203/00006450-197509000-00006'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1203/00006450-197509000-00006'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1203/00006450-197509000-00006'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1203/00006450-197509000-00006'


 

This table displays all metadata directly associated to this object as RDF triples.

173 TRIPLES      20 PREDICATES      45 URIs      37 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1203/00006450-197509000-00006 schema:about N029d8af865fd42b59d17e454deb149a1
2 N07a6f859b5044251968e1dfbde029d07
3 N165c103c7619454ea8b722dac7e340ec
4 N41cd171bad904c968e75c67036410bf9
5 N54a118f4005241c699b3e26c41db8aa1
6 N5768e38ec5b24b948d4a3695e327068a
7 N60442cdaaaea49fbacc30c8ddc2081c7
8 N7d158a5bc9c042229642c1ee90707cdd
9 N824620cd6e0e473cb5e86484e6164377
10 N830a27085818442f906b8cb1991b2977
11 N9168deb900d94d3e9d3c11416503e79b
12 Na2f59e194ef94d3f81fc3aa6e6998d6a
13 Na5a0e435ddfd481fbc56632ab37db1b5
14 Ncb2fc31ca6ca41bfa4bf34c415f7b644
15 Ne000780f2a5b4facaf9d51a178d7e3cf
16 Ne37e915760e942a9af784f9f178b27a3
17 anzsrc-for:17
18 anzsrc-for:1701
19 schema:author N7e70d22758624b1c84642830fc0d548b
20 schema:datePublished 1975-09
21 schema:datePublishedReg 1975-09-01
22 schema:description Pyritinol-HCl was tested for its impact on the cognitive functions of children with learning disabilities. This study is a contribution to scientific discussion on the complicated methodologic problems in evaluating the clinical efficacy of psychopharmacologic agents. Sixty-seven pupils of slow learner classes between the ages of 11 and 16 years were treated for 6 months with 300 mg pyritinol-HCl/24 hr or placebo under strict double-blind conditions. Drug intake was stimulated and controlled by means of intense psychosocial interaction with the mothers of the subjects. The dependence variables used to test medication effects were 22 parameters of cognitive performance measured in psychologic tests for perceptual and intellectual functions which were administered immediately before and after the medication phase. First the gainscores before and after treatment with pyritinol or placebo within the 22 cognitive parameters were statistically compared. In addition, an analysis of covariance on the corrected results of the second test (treating the results of first testing as covariates) and a two group discriminant analysis for overall differences were performed. None of the 22 parameters showed statistically significant treatment effects with respect to average performance (t (pyritinol - placebo) = 1.96 to 1.31), neither could the two groups be separated by discriminant analysis (Hotelling's T2 = 35.4, df - 22 and 43, P = 0.465). With respect to a variability of gainscores, however, in four parameters there was a significantly higher variance in the pyritinol group (F = 1.85-2.33, P less than 0.05, less than 0.02, respectively). This fact may signify that pyritinol-HCl had different effects on different subjects. By means of prognostic stratification we therefore attempted to define objective criteria for a selection of subjects with probable positive treatment effects. None of the 15 tested criteria, such as body weight, age, perceptual handicaps, or reduced short term memory, IQ range, proved, however, to be critical for a prognosis of pyritinol effects within the present test population.
23 schema:genre research_article
24 schema:inLanguage en
25 schema:isAccessibleForFree true
26 schema:isPartOf N3e7b66b001184693adcaeac5ca008fee
27 Nd7024b0ab1cd495a9907094fbe2e7787
28 sg:journal.1007352
29 schema:name Pyritinol Hydrochloride and Cognitive Functions: Influence on Children in Slow Learner Classes
30 schema:pagination 717
31 schema:productId N3a0ba792af9249788f495ebb269cb3a4
32 N604fdf25f192499d8f98a8b0917a30a5
33 N625019f6efc847f0879fdad7fcdae6d1
34 N74977acc7e144d00bbf700f3defd5ae5
35 Na4f8733642bf4660a5b95ddf9a8e9e6c
36 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030675497
37 https://doi.org/10.1203/00006450-197509000-00006
38 schema:sdDatePublished 2019-04-10T17:19
39 schema:sdLicense https://scigraph.springernature.com/explorer/license/
40 schema:sdPublisher Nd98b1cb176684fcea2dbc11c78e456a2
41 schema:url https://www.nature.com/articles/pr1975227
42 sgo:license sg:explorer/license/
43 sgo:sdDataset articles
44 rdf:type schema:ScholarlyArticle
45 N029d8af865fd42b59d17e454deb149a1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
46 schema:name Pyridines
47 rdf:type schema:DefinedTerm
48 N07a6f859b5044251968e1dfbde029d07 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
49 schema:name Body Weight
50 rdf:type schema:DefinedTerm
51 N15dd00c7badd4642805c989477d8b6da rdf:first N2d979cc4b18c467b81310373f7d9eec6
52 rdf:rest N19154dfbfdf14c0f9948aacef4d094e6
53 N165c103c7619454ea8b722dac7e340ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
54 schema:name Placebos
55 rdf:type schema:DefinedTerm
56 N19154dfbfdf14c0f9948aacef4d094e6 rdf:first sg:person.07671227605.11
57 rdf:rest N835ac04e911c43d7bc58691c4bec39a7
58 N2d979cc4b18c467b81310373f7d9eec6 schema:affiliation https://www.grid.ac/institutes/grid.5734.5
59 schema:familyName Schild
60 schema:givenName J
61 rdf:type schema:Person
62 N3970de6581524e49b699cca987cd005c rdf:first sg:person.071566117.24
63 rdf:rest Nf04811ea91bd40a4a43bd14aed297e6a
64 N3a0ba792af9249788f495ebb269cb3a4 schema:name nlm_unique_id
65 schema:value 0100714
66 rdf:type schema:PropertyValue
67 N3e7b66b001184693adcaeac5ca008fee schema:issueNumber 9
68 rdf:type schema:PublicationIssue
69 N41cd171bad904c968e75c67036410bf9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Clinical Trials as Topic
71 rdf:type schema:DefinedTerm
72 N41d8ceb6b0764f38903c3258f870a0a1 rdf:first Ncc1b7b84a1344013ad22df66b828bb87
73 rdf:rest N15dd00c7badd4642805c989477d8b6da
74 N54a118f4005241c699b3e26c41db8aa1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Humans
76 rdf:type schema:DefinedTerm
77 N5768e38ec5b24b948d4a3695e327068a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Drug Evaluation
79 rdf:type schema:DefinedTerm
80 N60442cdaaaea49fbacc30c8ddc2081c7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Memory, Short-Term
82 rdf:type schema:DefinedTerm
83 N604fdf25f192499d8f98a8b0917a30a5 schema:name pubmed_id
84 schema:value 1105370
85 rdf:type schema:PropertyValue
86 N625019f6efc847f0879fdad7fcdae6d1 schema:name readcube_id
87 schema:value 92226115291bac5201d2f0ebc9ea8d5719f2e711357cb56e571702b026f45a32
88 rdf:type schema:PropertyValue
89 N74977acc7e144d00bbf700f3defd5ae5 schema:name dimensions_id
90 schema:value pub.1030675497
91 rdf:type schema:PropertyValue
92 N7d158a5bc9c042229642c1ee90707cdd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Cognition
94 rdf:type schema:DefinedTerm
95 N7e70d22758624b1c84642830fc0d548b rdf:first sg:person.066315337.20
96 rdf:rest N41d8ceb6b0764f38903c3258f870a0a1
97 N824620cd6e0e473cb5e86484e6164377 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Intelligence Tests
99 rdf:type schema:DefinedTerm
100 N830a27085818442f906b8cb1991b2977 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Perception
102 rdf:type schema:DefinedTerm
103 N835ac04e911c43d7bc58691c4bec39a7 rdf:first sg:person.0104106472.42
104 rdf:rest N3970de6581524e49b699cca987cd005c
105 N9168deb900d94d3e9d3c11416503e79b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Child
107 rdf:type schema:DefinedTerm
108 Na2f59e194ef94d3f81fc3aa6e6998d6a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Pyrithioxin
110 rdf:type schema:DefinedTerm
111 Na4f8733642bf4660a5b95ddf9a8e9e6c schema:name doi
112 schema:value 10.1203/00006450-197509000-00006
113 rdf:type schema:PropertyValue
114 Na5a0e435ddfd481fbc56632ab37db1b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Adolescent
116 rdf:type schema:DefinedTerm
117 Ncb2fc31ca6ca41bfa4bf34c415f7b644 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Attention
119 rdf:type schema:DefinedTerm
120 Ncc1b7b84a1344013ad22df66b828bb87 schema:affiliation https://www.grid.ac/institutes/grid.5734.5
121 schema:familyName Kuenzler
122 schema:givenName M
123 rdf:type schema:Person
124 Nd7024b0ab1cd495a9907094fbe2e7787 schema:volumeNumber 9
125 rdf:type schema:PublicationVolume
126 Nd98b1cb176684fcea2dbc11c78e456a2 schema:name Springer Nature - SN SciGraph project
127 rdf:type schema:Organization
128 Ne000780f2a5b4facaf9d51a178d7e3cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Learning Disorders
130 rdf:type schema:DefinedTerm
131 Ne37e915760e942a9af784f9f178b27a3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Age Factors
133 rdf:type schema:DefinedTerm
134 Nf04811ea91bd40a4a43bd14aed297e6a rdf:first sg:person.0732503263.77
135 rdf:rest rdf:nil
136 anzsrc-for:17 schema:inDefinedTermSet anzsrc-for:
137 schema:name Psychology and Cognitive Sciences
138 rdf:type schema:DefinedTerm
139 anzsrc-for:1701 schema:inDefinedTermSet anzsrc-for:
140 schema:name Psychology
141 rdf:type schema:DefinedTerm
142 sg:journal.1007352 schema:issn 0031-3998
143 1530-0447
144 schema:name Pediatric Research
145 rdf:type schema:Periodical
146 sg:person.0104106472.42 schema:affiliation https://www.grid.ac/institutes/grid.5734.5
147 schema:familyName Pavlincova
148 schema:givenName E
149 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0104106472.42
150 rdf:type schema:Person
151 sg:person.066315337.20 schema:affiliation https://www.grid.ac/institutes/grid.5734.5
152 schema:familyName Wälti
153 schema:givenName U
154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.066315337.20
155 rdf:type schema:Person
156 sg:person.071566117.24 schema:affiliation https://www.grid.ac/institutes/grid.5734.5
157 schema:familyName Bircher
158 schema:givenName J
159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.071566117.24
160 rdf:type schema:Person
161 sg:person.0732503263.77 schema:affiliation https://www.grid.ac/institutes/grid.5734.5
162 schema:familyName Herschkowitz
163 schema:givenName N
164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0732503263.77
165 rdf:type schema:Person
166 sg:person.07671227605.11 schema:affiliation https://www.grid.ac/institutes/grid.5734.5
167 schema:familyName Vassella
168 schema:givenName F
169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07671227605.11
170 rdf:type schema:Person
171 https://www.grid.ac/institutes/grid.5734.5 schema:alternateName University of Bern
172 schema:name Departments of Pediatrics, Neurology, and Clinical Pharmacology, University of Berne, Berne, Switzerland
173 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...